Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H14N2O |
Molecular Weight | 154.2096 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CO\N=C\C1=CCCN(C)C1
InChI
InChIKey=YMMXHEYLRHNXAB-RMKNXTFCSA-N
InChI=1S/C8H14N2O/c1-10-5-3-4-8(7-10)6-9-11-2/h4,6H,3,5,7H2,1-2H3/b9-6+
Molecular Formula | C8H14N2O |
Molecular Weight | 154.2096 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Milameline (previously known as RU 35926/CI-979), a partial muscarinic agonist that was developed as a cognition-enhancing agent for the treatment of patients with Alzheimer's disease. In spite of this drug has achieved phase III clinical trials, further studies were apparently discontinued.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Preclinical and phase 1 clinical characterization of CI-979/RU35926, a novel muscarinic agonist for the treatment of Alzheimer's disease. | 1995 |
|
Combined cerebral blood flow effects of a cholinergic agonist (milameline) and a verbal recognition task in early Alzheimer's disease. | 2006 Oct |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10188788
CI-979/RU35926 (milameline) was well tolerated at doses of 0.002-1.0 mg with cholinergic symptoms such as hypersalivation and sweating, observed at 2-4 mg.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:37:37 GMT 2023
by
admin
on
Fri Dec 15 18:37:37 GMT 2023
|
Record UNII |
R9X77R42FN
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47796
Created by
admin on Fri Dec 15 18:37:37 GMT 2023 , Edited by admin on Fri Dec 15 18:37:37 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
139886-32-1
Created by
admin on Fri Dec 15 18:37:37 GMT 2023 , Edited by admin on Fri Dec 15 18:37:37 GMT 2023
|
PRIMARY | |||
|
SUB08961MIG
Created by
admin on Fri Dec 15 18:37:37 GMT 2023 , Edited by admin on Fri Dec 15 18:37:37 GMT 2023
|
PRIMARY | |||
|
R9X77R42FN
Created by
admin on Fri Dec 15 18:37:37 GMT 2023 , Edited by admin on Fri Dec 15 18:37:37 GMT 2023
|
PRIMARY | |||
|
DTXSID401028867
Created by
admin on Fri Dec 15 18:37:37 GMT 2023 , Edited by admin on Fri Dec 15 18:37:37 GMT 2023
|
PRIMARY | |||
|
100000080612
Created by
admin on Fri Dec 15 18:37:37 GMT 2023 , Edited by admin on Fri Dec 15 18:37:37 GMT 2023
|
PRIMARY | |||
|
Milameline
Created by
admin on Fri Dec 15 18:37:37 GMT 2023 , Edited by admin on Fri Dec 15 18:37:37 GMT 2023
|
PRIMARY | |||
|
9571002
Created by
admin on Fri Dec 15 18:37:37 GMT 2023 , Edited by admin on Fri Dec 15 18:37:37 GMT 2023
|
PRIMARY | |||
|
C132273
Created by
admin on Fri Dec 15 18:37:37 GMT 2023 , Edited by admin on Fri Dec 15 18:37:37 GMT 2023
|
PRIMARY | |||
|
7401
Created by
admin on Fri Dec 15 18:37:37 GMT 2023 , Edited by admin on Fri Dec 15 18:37:37 GMT 2023
|
PRIMARY | |||
|
C084978
Created by
admin on Fri Dec 15 18:37:37 GMT 2023 , Edited by admin on Fri Dec 15 18:37:37 GMT 2023
|
PRIMARY | |||
|
CHEMBL151938
Created by
admin on Fri Dec 15 18:37:37 GMT 2023 , Edited by admin on Fri Dec 15 18:37:37 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|